DIN 02318253 — REBIF 66 MCG
REBIF is a solution of Interferon Beta-1a marketed by EMD SERONO, A DIVISION OF EMD INC., CANADA. The full Interferon Beta-1a monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02318253
- Brand name
- REBIF
- Active ingredient
- Interferon Beta-1a
- Strength
- 66 MCG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- EMD SERONO, A DIVISION OF EMD INC., CANADA
- Health Canada status
- MARKETED
- Drug class
- Immunomodulator (interferon beta)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Interferon Beta-1a products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02269201 | AVONEX | 30 MCG | SOLUTION | BIOGEN CANADA INC | MARKETED |
| 02318261 | REBIF | 132 MCG | SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | MARKETED |
| 02237319 | REBIF | 22 MCG | SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | MARKETED |
| 02237320 | REBIF | 44 MCG | SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | MARKETED |